Atlas Trials

Furiex Pharmaceuticals, Inc

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Furiex Pharmaceuticals, Inc

RecordFirmDate
Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (NCT01553747)Furiex Pharmaceuticals, Inc2012-05-29
Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) (NCT01553591)Furiex Pharmaceuticals, Inc2012-05-29
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM) (NCT01279590)Furiex Pharmaceuticals, Inc2011-03-01
Efficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring Hospitalization for Community-Acquired Bacterial Pneumonia (NCT01198626)Furiex Pharmaceuticals, Inc2010-10-01
Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared to Linezolid (Zyvox) (NCT01128530)Furiex Pharmaceuticals, Inc2010-06-01
Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea (NCT01130272)Furiex Pharmaceuticals, Inc2010-04-28

Track Furiex Pharmaceuticals, Inc automatically

Every clearance here is in the API, with alerts when new ones post.